The Management of Cancer Patients: Separate Research Experiences with Gemcitabine HCL and DAB389IL-2 Fusion Protein : Based on Scientific Proceedings of an Eli Lilly and Company Satellite Symposium at the 8th European Conference on Clinical Oncology and C
Inhalt Karte:
2 MANAGEMENT 312.098 [Oxford :Pergamon Press, 1997]. - [4], 36 s. ; 28 cm. - (The European Journal of Cancer, ISSN 0959-8049 ; vol.33, suppl.1)
